“Today the CDC released the 2022 National Diabetes Statistics Report estimating that in 2019, there were 1.84 million Americans living with type 1 diabetes. This data, and additional statistical research reinforces the urgency to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. JDRF as the leading global research and advocacy T1D organization is committed to supporting the entire community to drive towards pivotal change in the diabetes space.”

-JDRF International 

About JDRF

JDRF’s mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.5 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our five international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter (@JDRF), Facebook (@myjdrf), and Instagram (@jdrfhq).